Enhancement of percutaneous absorption of naproxen by phospholipids

被引:47
作者
Valjakka-Koskela, R
Kirjavainen, M
Mönkkönen, J
Urtti, A
Kiesvaara, J
机构
[1] Orion Corp Orion Pharma, FIN-70701 Kuopio, Finland
[2] Univ Kuopio, Dept Pharmaceut, FIN-70211 Kuopio, Finland
[3] Orion Corp Orion Pharma, FIN-20101 Turku, Finland
关键词
ethanol; gel; naproxen; percutaneous absorption; phospholipid;
D O I
10.1016/S0378-5173(98)00285-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin penetration of naproxen from various phospholipid gel formulations through human cadaver skin was investigated in diffusion chambers. Presence of phospholipids decreased the skin penetration of naproxen from aqueous gels. The addition of 32% (m/m) ethanol or propylene glycol in the aqueous gel formulation, with the presence of phospholipids, apparently increased the percutaneous absorption of naproxen. The penetration enhancement effect of phospholipid with ethanol was, however, more significant than that of phospholipid with propylene glycol. The effect of ethanol concentration on the ability of phospholipids to increase penetration of naproxen, was evaluated in pretreatment studies. The results showed that more than 8% (m/v) ethanol is needed for the enhancing effect of phospholipids. The concentration of phospholipid and the presence of unsaturated fatty acids in phospholipids are also important factors affecting the transdermal flux of naproxen. In conclusion, in the presence of cosolvent, phospholipids increase the transdermal flux of naproxen. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 16 条
[1]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[2]   DERMAL DRUG DELIVERY BY LIPOSOME ENCAPSULATION - CLINICAL AND ELECTRON-MICROSCOPIC STUDIES [J].
FOLDVARI, M ;
GESZTES, A ;
MEZEI, M .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (04) :479-489
[3]   INFLUENCE OF LIPOSOMAL DRUG ENTRAPMENT ON PERCUTANEOUS-ABSORPTION [J].
GANESAN, MG ;
WEINER, ND ;
FLYNN, GL ;
HO, NFH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 20 (1-2) :139-154
[4]   EFFECT OF EGG-YOLK LECITHIN ON TRANSDERMAL DELIVERY OF BUNAZOSIN HYDROCHLORIDE [J].
KATO, A ;
ISHIBASHI, Y ;
MIYAKE, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (05) :399-400
[5]  
KIMURA T, 1989, CHEM PHARM BULL, V37, P454
[6]   Interaction of liposomes with human skin in vitro - The influence of lipid composition and structure [J].
Kirjavainen, M ;
Urtti, A ;
Jaaskelainen, I ;
Suhonen, TM ;
Paronen, P ;
ValjakkaKoskela, R ;
Kiesvaara, J ;
Monkkonen, J .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (03) :179-189
[7]  
KIRJAVAINEN M, 1998, IN PRESS EUR J PHARM
[8]   EFFECT OF EGG-YOLK LECITHINS AND COMMERCIAL SOYBEAN LECITHINS ON INVITRO SKIN PERMEATION OF DRUGS [J].
MAHJOUR, M ;
MAUSER, B ;
RASHIDBAIGI, Z ;
FAWZI, MB .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (03) :243-252
[9]  
NISHIHATA T, 1987, CHEM PHARM BULL, V35, P3807
[10]  
SINGH P, 1994, J PHARMACOL EXP THER, V268, P144